Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RNR
RNR logo

RNR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Renaissancere Holdings Ltd (RNR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
312.800
1 Day change
-0.76%
52 Week Range
318.200
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

RenaissanceRe Holdings Ltd (RNR) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the technical indicators show a bullish trend, the lack of strong positive catalysts, insider selling activity, and weak financial performance in the latest quarter suggest caution. The stock may not provide optimal long-term growth potential given the current data.

Technical Analysis

The technical indicators are showing a bullish trend. The MACD is positive and expanding, the RSI is neutral at 76.992, and the moving averages (SMA_5 > SMA_20 > SMA_200) indicate upward momentum. The current pre-market price is $308.99, which is above the pivot level of $303.127 but below the first resistance level of $313.5.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • The stock shows a 40% chance of gaining 2.65% in the next week based on historical patterns.

Neutral/Negative Catalysts

  • Insider selling has increased significantly by 432.14% over the last month. Financial performance in Q4 2025 shows a significant drop in net income (-477.23% YoY) and EPS (-530.59% YoY). No recent news or congress trading data to support a positive sentiment.

Financial Performance

In Q4 2025, revenue increased by 3.41% YoY to $2.93 billion. However, net income dropped significantly by -477.23% YoY to $739.12 million, and EPS fell by -530.59% YoY to 16.75. Gross margin remained flat at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed on RNR. While some firms like Cantor Fitzgerald and Barclays have raised price targets and provided positive outlooks, others like Morgan Stanley have downgraded the stock to Equal Weight, citing valuation concerns and pricing pressure in the casualty sector.

Wall Street analysts forecast RNR stock price to fall
11 Analyst Rating
Wall Street analysts forecast RNR stock price to fall
3 Buy
7 Hold
1 Sell
Hold
Current: 312.800
sliders
Low
267
Averages
308.36
High
455
Current: 312.800
sliders
Low
267
Averages
308.36
High
455
BofA
Buy
to
Buy
downgrade
$473 -> $426
AI Analysis
2026-04-14
Reason
BofA
Price Target
$473 -> $426
AI Analysis
2026-04-14
downgrade
Buy
to
Buy
Reason
BofA lowered the firm's price target on RenaissanceRe to $426 from $473 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance coverage to reflect Q4 events and changes to peer multiples.
Mizuho
Yaron Kinar
Neutral
maintain
$313 -> $318
2026-04-13
Reason
Mizuho
Yaron Kinar
Price Target
$313 -> $318
2026-04-13
maintain
Neutral
Reason
Mizuho analyst Yaron Kinar raised the firm's price target on RenaissanceRe to $318 from $313 and keeps a Neutral rating on the shares. The firm adjusted estimates and targets among its North America insurance coverage, stating that it is most constructive on brokers, expects commercial pricing pressure moderation among property and casualty insurers and believes the setup for life insurers is "the most challenging."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RNR
Unlock Now

People Also Watch